Clinithink is a technology and artificial intelligence services company, founded in 2009, with bases in the United States and in the United Kingdom. Clinithink patented an artificial intelligence program they developed called CLiX. CLiX is a language processing program that combs unstructured medical patient charts and returns the data to the system with structure.
Clinithink was developed due to lack of conformity in medical charting practices.
Clinithink currently holds an Early Stage Venture funding status. Their last funding round was a Series B funding round that raised an unspecified amount of money in 2019. The previous funding rounds that were classified as Series A, took place in April & July of 2012. The lead investors in Clinithink are Merck and TT Capital Partners, however Vanguard Atlantic and Development Bank of Wales also made investments in the Series A - Clinithink Funding Round.
Clinithink and Healthix harness benefits of AI and massive health data
BioSpectrum - Asia Edition
August 16, 2019
Clinithink Integrates With Healthitx HIE to Facilitate Assessment of Pre-Trial Feasibility -
August 14, 2019
Clinithink Secures Growth-Equity Investment to Fuel Growth
January 8, 2019
Clinithink Wins Two AIconics 2019 Awards in San Francisco
October 1, 2019